Afalaza resorption pills 100 pcs
Condition: New product
998 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Antibodies to prostate-specific antigen affinity purified
Release form
Pills
Composition
Choline salicylate, excipients: glycerol - 0.13 g; ethanol 96% - 0.1 g; chlorbutanol - 0.005 g; purified water - up to 1 g;
Pharmacological effect
Reduces the effects of inflammation and edema in the prostate gland, normalizes its functional state. Improves urodynamics, reduces the amount of residual urine, normalizes the tone of the lower urinary tract, helps reduce dysuric disorders;
Pharmacokinetics
The sensitivity of modern physicochemical methods of analysis (gas-liquid chromatography, high-performance liquid chromatography, chromatography-mass spectrometry) does not allow to evaluate the content of ultra-low doses of antibodies in biological fluids, organs and tissues, which makes it impossible to study the pharmacokinetics of the drug Afalaza;
Indications
Benign prostatic hyperplasia of stage I and II. ; In the complex treatment of acute and chronic prostatitis - as an anti-inflammatory and analgesic. ; Dysuric disorders (frequent urge to urinate, including nocturnal, difficulty urinating, pain or discomfort in the perineal region), including those accompanying benign prostatic hyperplasia stage I and II; acute and chronic prostatitis;
Contraindications
Increased individual sensitivity to the components of the drug;
Use during pregnancy and lactation
The drug is not used in women;
Dosage and administration
Inside At one time 2 pills (keep in the mouth until completely dissolved - not during the meal). The drug is taken twice a day, in the evening and in the morning (before and after sleep). The recommended duration of the drug is 16 weeks. With marked pain syndrome and dysuric disorders in the first 2-3 weeks of therapy, the drug is indicated up to 4 times per day. ; If necessary, on the recommendation of a doctor, it is possible to repeat the course of treatment after 1 to 4 months;
Side effects
When using the drug for the indicated indications and in the indicated dosages, no side effects were revealed;
Overdose
In case of accidental overdose, dyspeptic symptoms are possible due to the fillers in the dosage form;
Interaction with other drugs
Cases of incompatibility with other drugs so far not registered. ;
special instructions
The preparation contains lactose, and therefore it is not recommended to prescribe it to patients with congenital galactosemia, glucose or malabsorption malabsorption syndrome, or with congenital lactase deficiency. Afalaza does not affect the ability to drive vehicles and other potentially dangerous machinery;